⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqCM

SLS

SELLAS Life Sciences Group, Inc.

Healthcare · Biotechnology

11.54USD

+0.1900 (+1.67%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on SLS.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 11.54
P/E—
Dvd Ind Yld0.0%
P/B16.93
P/S—
Curr EV/T12M EBITDA—
Mkt Cap (USD)2.3B
Curr EV (USD)2.2B
2)

Per Share Data

EPS T12M-0.23
DPS0.00
Bk Val Per Sh0.68
Rev/Sh0.00
Cash/Sh0.69
Curr Shares Out201.9M
FCF/Sh-0.06
3)

Cash Flow Analysis

P/CF-82.0
Curr P/FCF-196.6
CF/NI0.9
Dvd P/O-1.2%
Cash Gen/Cash Reqd-74.4
Csh Dvd Cov-75.6
CFO/Sales—
Eff Interest Rate—
4)

Growth Potential

Dil EPS 1Y Gr50.0%
Cap 1Y Gr648.8%
BPS 1Y Gr320.2%
R&D To Sales—
Retention Rate101.2%
Rev 1Y Gr-100.0%
FCF 1Y Gr75.5%
Assets 1Y Gr303.2%
5)

Profitability

EBITDA-0.0B
EBIT-0.0B
Operating Margin0.0%
Pretax Margin—
Net Margin0.0%
ROA-36.5%
ROE-39.6%
ROC-25.0%
Asset Turnover0.00
6)

Structure

Current Ratio18.83
Quick Ratio18.28
Debt/Assets0.0%
Debt/Com Eq0.0%
Net Debt/EBITDA24.13
Tot Debt/Capital0.0%
Gross Margin0.0%
EBIT/Int Exp—

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.